Devices that are used to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI) are referred to as female pelvic implants. The procedures employed to treat these conditions/disorders involve placing of pelvic implant devices inside the patient’s vagina. The rate of incidence of vaginal disorders is high among elderly population. In most cases, these disorders cause distress, leading to discomfort in the regular life. Surgical procedures utilized to treat POP or SUI may or may not involve the use of female pelvic implants. In case of procedures wherein these implants are employed, the products utilized can be classified into three distinct types: vaginal slings, vaginal mesh implants, and vaginal graft implants. Owing to complex anatomy of the acetabulum and the pelvic ring, complexity of the procedure calls for exact anatomical reduction and hence obtain positive functional results. Thus, implantation of pelvic devices are needed to be performed with utmost meticulousness.
Pelvic organ prolapse and stress urinary incontinence are prevalent among about 80% of women suffering from dysfunction of the pelvic floor. The incidence of pelvic organ prolapse is more common in developing as well as developed countries. According to the Association for Pelvic Organ Prolapse Support, approximately 34 million women suffer from POP across the globe currently. In the U.S., the total number of patients with pelvic organ prolapse is 3.3 million. According to the National Association for Incontinence, 25 million adult individuals in the U.S. suffer from one or the other form of urinary incontinence, out of which 75% to 80% are women. On the global scale, the number is estimated to be 200 million. Stress urinary incontinence is the most prevalent form of urinary incontinence. In the U.S., the number of adult individuals suffering from SUI is approximately 15 million. Rising prevalence of pelvic organ prolapse and stress urinary incontinence is propelling the female pelvic implants market. However, increasing rate of complications in pelvic organ prolapse and low rate of efficacy after pelvic implantation are major restraints of the global female pelvic implants market, especially the vaginal mesh implants segment. It has been assessed that one in every 15 women, who have undergone pelvic implantation, has been forced to surgically extract the implant, due to increased complications associated with the vaginal mesh implant. In Australia, approximately 10,000 to 15,000 women suffered from side-effects of using vaginal mesh devices in 2018.
The global female pelvic implants market can be segmented based on product type, indication type, end-user, and region. In terms of product type, the market can be categorized into vaginal mesh implants, vaginal slings, and vaginal graft implants. Based on indication type, the female pelvic implants market can be divided into pelvic organ prolapse (POP) and stress urinary incontinence (SUI). In terms of end-user, the female pelvic implants market can be classified into hospitals, ambulatory surgical centers, and specialty clinics.
In terms of geography, the global pelvic implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to account for a major share of the global market by the end of 2018, due to favorable rules, regulations, and reimbursement policies of governments and increasing health care expenditure in the region. Europe, followed by Asia Pacific, is projected to be a highly lucrative market for female pelvic implants in the near future. The female pelvic implants market in Asia Pacific is expected to expand rapidly during the forecast period. Increasing population and rising incidence of pelvic organ prolapse and stress urinary incontinence are expected to drive the market in the region in the next few years. Furthermore, increasing awareness among women regarding complications in and treatment of POP and SUI and rising investments in R&D activities in the region are anticipated to promote growth of the female pelvic implants market in Asia Pacific between 2018 and 2026. The pelvic implants market in Middle East & Africa and Latin America is likely to expand substantially during the forecast period, due to introduction of favorable government policies and increase in the expenditure on health care by both public and private bodies in these regions.
Key players operating in the global female pelvic implants market are Johnson & Johnson Services, Inc., Coloplast Group, BD (Becton, Dickinson and Company), Boston Scientific Corporation, PFM Medical AG, Cook, Betatech Medical, Dipromed Srl, Promedon, and Caldera Medical.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.